Indeed, a low dose of anti-Ly6G, which ligates Ly6G and, thereby, reduces neutrophil surface expression of integrins and, consequently, integrin binding to ICAM-1 (without inducing neutrophil death)58, increased CBF in AD mice but not in WT mice (Extended Data Fig. 7j,k). Here, ICAM1 is linked to Alzheimer disease.